InsidersTradesSigma
Follow the Anthem Biosciences share price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €505.9bn. The latest transaction was reported on 16 July 2026 (Disposal). Among the most active insiders: Aruna Ganesh. Every trade is free.
Analysts rate Anthem Biosciences Strong Buy (bullish), based on 8 analysts. Average price target: ₹905.13.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Anthem Biosciences is a biotechnology company that provides research and development services for innovative health solutions. It operates in the XBOM market.